A Schlemmer Selected Research

Triamcinolone (Aristocort)

4/2017

Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A Schlemmer Research Topics

Disease

4	Rheumatoid Arthritis 01/2019 - 04/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Psoriatic Arthritis 01/2018
1	Rheumatic Diseases (Rheumatism) 09/2016
1	Blindness (Hysterical Blindness) 07/2002
1	Osteoporosis 07/2002

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2016
3	Adalimumab (Humira)FDA Link 04/2017 - 04/2016
2	Methotrexate (Mexate)FDA LinkGeneric 04/2017 - 09/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018
1	Analgesics (Analgesic Drugs)IBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Triamcinolone (Aristocort)FDA Link 04/2017
1	triamcinolone hexacetonide (Aristospan)FDA Link 09/2016
1	C-Reactive ProteinIBA 09/2016
1	Circulating MicroRNAIBA 04/2016
1	salmon calcitonin (Calcimar)FDA LinkGeneric 07/2002
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2002

Therapy/Procedure

1	Therapeutics 09/2016
1	Bed Rest (Bedrest) 07/2002